ENANTA PHARMACEUTICALS INC (ENTA) Institutional Ownership

ENTA is currently held by 1 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $8.40M based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $8.40M in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, Renaissance Technologies LLC's ENTA position is now estimated to be worth approximately $8.41M, representing an estimated gain of +0.08% since the filing period.

Major shareholders tracked on this page include Renaissance Technologies LLC, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks fund ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward ENANTA PHARMACEUTICALS INC (ENTA).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20261$8,402,209665,258
Q4 20251$10,127,494642,200
Q3 20251$5,740,812479,600
Q2 20251$3,549,420469,500
Q1 20251$2,559,072463,600
Q4 20241$2,863,500498,000
Q3 20241$5,437,964524,900
Q2 20241$6,626,373510,900
Q1 20241$9,186526,100
Q4 20231$5,255558,500
Q3 20231$5,117458,100
Q2 20231$10,193476,300

Related ENTA Institutional Insights: